Literature DB >> 14686641

Controlling blood pressure in 50% of all hypertensive patients: an achievable goal in the healthy people 2010 report?

Brent M Egan1, Jan N Basile.   

Abstract

BACKGROUND: One important objective defined in the Healthy People 2010 report was to improve blood pressure (BP) control to < 140/90 mm Hg in 50% of all hypertensive patients. Because the US population is becoming older, more obese, and ethnically diverse, the health and economic benefits of reaching this goal become more valuable each year. Hypertension control rates are currently at approximately 31% of all hypertensives and have risen slowly and erratically since 1988. In the absence of a coordinated strategic plan, achieving this critically important goal for BP control is highly unlikely.
METHODS: A selected literature review was undertaken to briefly assess the cardiovascular benefits of controlling hypertension. Greater focus was placed on variables that impact hypertension awareness, treatment, and control. The impact on hypertension control rates of theoretic changes in awareness, treatment, and control individually and collectively was examined. Four categories of potential barriers to optimizing BP control are discussed: systems, provider, patient, and treatment factors.
RESULTS: Raising awareness to 80% of all hypertensives, ensuring treatment of 90% of aware hypertensives, and controlling BP to < 140/90 mm Hg in 70% of treated patients would achieve control rates of 50%.
CONCLUSIONS: The barriers to achieving the Healthy People 2010 goal of controlling hypertension in 50% of all patients are formidable but appear to be resolvable with a coordinated strategic plan. Given projected demographic changes in the United States, the health and economic benefits of attaining the national goal for hypertension control would seem to merit a serious integrated effort.

Entities:  

Mesh:

Year:  2003        PMID: 14686641     DOI: 10.1136/jim-51-06-34

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  9 in total

1.  Long-term efficacy and safety of triple-combination therapy with olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide for hypertension.

Authors:  Dean J Kereiakes; Steven G Chrysant; Joseph L Izzo; Thomas Littlejohn; Suzanne Oparil; Michael Melino; James Lee; Victor Fernandez; Reinilde Heyrman
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-01-24       Impact factor: 3.738

Review 2.  Achieving blood pressure goals: why aren't we?

Authors:  William C Cushman; Jan Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

3.  Cardiovascular risk factor control in communities--update from the ASH Carolinas-Georgia Chapter, the Hypertension Initiative, and the Community Physicians' Network.

Authors:  Brent M Egan; Daniel T Lackland; Priscilla Igho-Pemu; Katharine H Hendrix; Jan Basile; Shakaib U Rehman; Eni C Okonofua; Alexander Quarshie; Adefisayo Oduwole; Anekwe Onwuanyi; James Reed; Chamberlain Obialo; Elizabeth O Ofili
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

4.  Barriers to and strategies for effective blood pressure control.

Authors:  David Siegel
Journal:  Vasc Health Risk Manag       Date:  2005

5.  Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study.

Authors:  Wenxin Xu; Saveli I Goldberg; Maria Shubina; Alexander Turchin
Journal:  BMJ       Date:  2015-02-05

6.  Sodium intake, dietary knowledge, and illness perceptions of controlled and uncontrolled rural hypertensive patients.

Authors:  Aziz Kamran; Leila Azadbakht; Gholamreza Sharifirad; Behzad Mahaki; Afshan Sharghi
Journal:  Int J Hypertens       Date:  2014-02-04       Impact factor: 2.420

7.  Psychometric testing of an instrument designed to measure nutritional perceptions of hypertensive patients.

Authors:  Aziz Kamran; Leila Azadbakht; Behzad Mahaki; Gholamreza Sharifirad
Journal:  J Educ Health Promot       Date:  2014-08-28

Review 8.  Combination therapy with an angiotensin-converting enzyme inhibitor and a calcium channel blocker.

Authors:  Brent M Egan
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-10       Impact factor: 3.738

9.  Rate and predictors of blood pressure control in a federal qualified health center in Michigan: a huge concern?

Authors:  Adesuwa B Olomu; Venu Gourineni; Jason L Huang; Nirzari Pandya; Nephertiti Efeovbokhan; Janaki Samaraweera; Kamesh Parashar; Margaret Holmes-Rovner
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-02-01       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.